Regarding treatment strategies, there was no significant difference in recurrence rates between stroke patients with isolated IgM APS positivity treated with antiplatelet agents and those treated with Vitamin K antagonists (VKAs) like warfarin [117]. The gene discussed is CD40LG; the disease is Stroke.